In the article by Santillan et al (Santillan MK, Santillan DA, Scroggins SM, Min JY, Sandgren JA, Pearson NA, Leslie KK, Hunter SK, Zamba GKD, Gibson-Corley KN, Grobe JL. Vasopressin in Preeclampsia: A Novel Very Early Human Pregnancy Biomarker and Clinically Relevant Mouse Model. Hypertension. 2014;64:852−859), which published online July 7, 2014, and appeared in the October 2014 issue of the journal, a correction was needed.
In Sources of Funding, the following grant information and disclaimer was added: “The study was also supported by National Institutes of Health (NIH) grant U54TR001013. The Institute for Clinical and Translational Science at the University of Iowa is supported by the NIH Clinical and Translational Science Award (CTSA) program, grant U54TR001013. The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS). This publication’s contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.”
The authors apologize for omitting this information.
This correction has been made to the current online version of the article, which is available at http://hyper.ahajournals.org/content/64/4/852.full.
- © 2014 American Heart Association, Inc.